Minister of Health Witnesses the Signing of a Memorandum of Understanding with Bristol Myers Squibb to Improve Health Care Services for Thalassemia Patients
Dr. Khaled Abdel Ghaffar, Minister of Health and Population, today, Thursday, witnessed the signing of a memorandum of understanding between the Egyptian Ministry of Health and Bristol Myers Squibb Middle East and Africa, aimed at improving the health care services provided to thalassemia patients and strengthening avenues of cooperation in the health sector, at the Ministry of Health headquarters in the New Administrative Capital.
Dr. Hossam Abdel Ghaffar, official spokesperson for the Ministry of Health and Population, explained that the memorandum of understanding was signed on behalf of the Ministry of Health by Dr. Mohamed Hassany, Assistant Minister of Health and Population for Public Health Initiatives, and on behalf of Bristol Myers Squibb Middle East and Africa by Mr. Oscar Delgado, the company's General Manager and legal representative, noting that the company is one of the world's leading biopharmaceutical companies in the discovery, development and delivery of medicines.
Abdel Ghaffar pointed out that under the memorandum of understanding, the burden and challenges of thalassemia will be studied across all governorates of the Republic, and work will be done to issue recommendations that would help develop the thalassemia treatment system, through bodies specialized in health economics, research and health policy, so that the necessary decisions can be taken to improve the patient's treatment journey.
Abdel Ghaffar added that under the memorandum of understanding, the efficiency and skills of health care providers for thalassemia patients will be raised through integrated, specialized training sessions and workshops to train medical teams in accordance with international standards in this field, noting that the memorandum includes the provision of a support program for thalassemia patients.
Abdel Ghaffar indicated that the Minister stressed that the memorandum would serve the Ministry's goals and achieve its vision of improving the services provided to thalassemia patients and facilitating their continuous access to innovative medicines, ensuring their protection from life-threatening diseases.